In a new article published in the Journal of the American Medical Association (JAMA), the U.S. Centers for Disease Control and Prevention (CDC) outlines concerns related to the sale of nicotine pouches and other synthetic nicotine products. The CDC shares that synthetic nicotine products have the potential to undermine youth tobacco prevention and cessation efforts. Further, the CDC highlights the similarities between the flavors and marketing of synthetic nicotine products to that of e-cigarettes -- tactics that the CDC points out have been successful in attracting young people. CDC concludes by arguing that these products warrant urgent action from policymakers, clinicians, and researchers.
Dec. 21, 2021Stanford website provides deep dive into the history of commercial tobacco marketing
Dec. 8, 2021New Wall Street Journal Podcast Examines the Rise of Puff Bar
Nov. 19, 2021
Jan. 18, 2022Youth hopes for a tobacco-free new year
Jan. 5, 2022Being tobacco-free is protection against COVID
Dec. 22, 2021How companies like Puff Bar have avoided FDA regulation: "The industry can innovate around it"
Dec. 16, 2021New Zealand's unique cigarette ban may be a model for other countries
Dec. 16, 2021